Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey

Michael R. Law, Lucy Cheng, Ashra Kolhatkar, Laurie J. Goldsmith, Steven G. Morgan, Anne M. Holbrook and Irfan A. Dhalla
February 13, 2018 6 (1) E63-E70; DOI: https://doi.org/10.9778/cmajo.20180008
Michael R. Law
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy Cheng
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashra Kolhatkar
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurie J. Goldsmith
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven G. Morgan
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne M. Holbrook
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
MDPharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irfan A. Dhalla
Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 6 no. 1 E63-E70
DOI 
https://doi.org/10.9778/cmajo.20180008
PubMed 
29440236
History 
  • Published online February 13, 2018.
Copyright & Usage 
Copyright 2018, Joule Inc. or its licensors

Author Information

  1. Michael R. Law, PhD,
  2. Lucy Cheng, MSc,
  3. Ashra Kolhatkar, MPH,
  4. Laurie J. Goldsmith, PhD,
  5. Steven G. Morgan, PhD,
  6. Anne M. Holbrook, MD, PharmD,
  7. Irfan A. Dhalla, MD, MSc
  1. Affiliations: Centre for Health Services and Policy Research (Law, Cheng, Kolhatkar); School of Population and Public Health (Law, Cheng, Kolhatkar, Morgan), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Goldsmith), Simon Fraser University, Burnaby, BC; Division of Clinical Pharmacology and Toxicology (Holbrook), Department of Medicine, McMaster University, Hamilton, Ont.; Health Quality Ontario (Dhalla); Li Ka Shing Knowledge Institute (Dhalla), St. Michael's Hospital; Institute for Clinical Evaluative Sciences (Dhalla), Toronto, Ont.
  1. Correspondence to:
    Michael Law, michael.law{at}ubc.ca
View Full Text

Usage statistics: February 2018 to August 2025

AbstractFullPdf
Feb 20182525138446
Mar 20181341108172
Apr 20186338071
May 20184423764
Jun 20189028367
Jul 20182855851
Aug 20183925746
Sep 20183923975
Oct 201844484178
Nov 201840346121
Dec 20184220847
Jan 20193234568
Feb 20192733093
Mar 201938538152
Apr 201920223145
May 20192822682
Jun 201922357113
Jul 201970306125
Aug 201928360104
Sep 201918479168
Oct 201927618224
Nov 201933487229
Dec 201918308179
Jan 202045461219
Feb 202044446218
Mar 202054424161
Apr 20202240574
May 20203759253
Jun 20203439837
Jul 20202424016
Aug 20202034124
Sep 20202539445
Oct 20207756090
Nov 20206751373
Dec 20204912765
Jan 20213217831
Feb 20215132043
Mar 202111727270
Apr 20214916845
May 20216220637
Jun 20214123250
Jul 2021222444
Aug 2021128234
Sep 2021834244
Oct 202122342110
Nov 20211726884
Dec 20211315648
Jan 20221926046
Feb 20222915146
Mar 20224849662
Apr 20224818041
May 20223227064
Jun 20222312245
Jul 20221512735
Aug 20221511020
Sep 20221718248
Oct 20223325961
Nov 20222435265
Dec 20222013224
Jan 20231921424
Feb 2023814729
Mar 20232214946
Apr 2023710830
May 2023910235
Jun 20237883692
Jul 2023115551300
Aug 202341162955
Sep 202361213905
Oct 20233727311
Nov 20231439660
Dec 20231226027
Jan 20241821944
Feb 2024316848
Mar 2024640151
Apr 2024126059
May 2024129140
Jun 2024621964
Jul 2024621164
Aug 2024317964
Sep 2024427581
Oct 20241027594
Nov 2024324688
Dec 2024225581
Jan 2025526094
Feb 2025830994
Mar 20259439109
Apr 2025648483
May 20256456106
Jun 2025633674
Jul 202520101393
Aug 20251025484
PreviousNext
Back to top

In this issue

CMAJ Open: 6 (1)
Vol. 6, Issue 1
1 Jan 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
Michael R. Law, Lucy Cheng, Ashra Kolhatkar, Laurie J. Goldsmith, Steven G. Morgan, Anne M. Holbrook, Irfan A. Dhalla
Jan 2018, 6 (1) E63-E70; DOI: 10.9778/cmajo.20180008

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
Michael R. Law, Lucy Cheng, Ashra Kolhatkar, Laurie J. Goldsmith, Steven G. Morgan, Anne M. Holbrook, Irfan A. Dhalla
Jan 2018, 6 (1) E63-E70; DOI: 10.9778/cmajo.20180008
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis
  • From Patient Voices to Policy: Data Analytics Reveals Patterns in Ontarios Hospital Feedback
  • Predictors of cost-related medication nonadherence in Canada: a repeated cross-sectional analysis of the Canadian Community Health Survey
  • Les defis du cout de la vie soulignent lurgence pour les medecins de prescrire des medicaments abordables
  • Cost-of-living challenges highlight urgency for clinicians to prescribe affordable medications
  • Biologic DMARD Access and Medication Cost-related Nonadherence in Rheumatology Patients in Canada: A Cross-sectional Survey
  • Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs
  • Acceptability of a short list of essential medicines to patients and prescribers: Multimethod study
  • Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis
  • Inciter les medecins a prescrire en se souciant davantage des couts: Strategie de changement
  • Engaging physicians to prescribe more cost-effectively: Blueprint for change
  • Drug coverage in Canada: gaps and opportunities
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Psychiatry
      • Drugs: psychiatry
    • Drugs
      • Other drug use
  • Nonclinical
    • Health Policy
      • Health care funding outside of medicare
    • Health Economics - see also Medicare
    • Patients
      • Other patients

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire